Explore how DNA and histone methylation are revolutionizing cancer diagnosis and treatment through epigenetic mechanisms.
Explore how decitabine, an epigenetic drug, reprograms cancer cells by reversing DNA methylation and reactivating silenced tumor suppressor genes.
Exploring the connection between P16INK4a promoter methylation and ovarian cancer through meta-analysis findings and clinical implications.
Exploring how DNA methylation patterns in TCF7L2 and GIPR genes contribute to Type 2 Diabetes development and potential diagnostic applications
Two decades of progress in glioma methylation research: the rise of temozolomide resistance and immunotherapy insights